Guido Felizzia

4PUBLICATIONS
67CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Gene and molecular therapyAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 15, 2026
Immune Response and Safety of Anti-NeuGcGM3 Anti-Idiotype Vaccine Racotumomab in Patients With High-Risk Neuroblastoma: An Open-Label, Single-Arm, Multicenter Phase 2 Study in Argentina.

|Feb 12, 2026
Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients.

Jean Donadieu, Dmitry Evseev, Francesco Pegoraro

|Dec 23, 2025
Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk Neuroblastoma.

Gabriela I Villanueva, Sandra Alarcón, Diana Bonilla

|Nov 22, 2022
Persistent spontaneous pneumothorax as a primary manifestation of primary synovial sarcoma of the lung: a case report.

M Macarena Oneglia, M Sol Fernández Sardá, Guido Felizzia

Pageof 1

Frequent Collaborators

1 joint publications

Jean Donadieu

1 joint publications

Dmitry Evseev

1 joint publications

Francesco Pegoraro

1 joint publications

Elena Sieni